Author details

Full Name

Frans Van de Werf

Affiliation

ORCID

Career Start Year

1973

Papers

699

H Index

106

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37439219	STREAM-2: Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment-Elevation Myocardial Infarction: A Randomized, Open-Label Trial.		2023
37838236	Secondary prevention therapies in real-world patients with myocardial infarction: eligibility based on randomized trials supporting European and American guidelines.		2023
37279841	Impact of standard modifiable cardiovascular risk factors on 2-year all-cause mortality: Insights from an international cohort of 23,489 patients with acute coronary syndrome.		2023
34175245	Sex differences in mortality after an acute coronary syndrome increase with lower country wealth and higher income inequality.	Revista espanola de cardiologia (English ed.)	2022
36018037	Polypill Strategy in Secondary Cardiovascular Prevention.	N Engl J Med	2022
35112113	Do clinical trial data suggest a role for SGLT2-inhibitors in primary prevention of heart failure and chronic kidney disease?	International Journal of Cardiology: Cardiovascular Risk and Prevention	2021
33537947	Long-Term Antithrombotic Therapy and Clinical Outcomes in Patients with Acute Coronary Syndrome and Renal Impairment: Insights from EPICOR and EPICOR Asia.	American Journal of Cardiovascular Drugs	2021
32804781	Trends in reperfusion therapy for acute ST-segment elevation myocardial infarction in an academic percutaneous coronary intervention center in the metropolitan area of a developing country: insights from the Jakarta Acute Coronary Syndrome registry.	Coronary Artery Disease	2021
33420682	Number of Antithrombotic Drugs Used Early and In-hospital Outcomes in Acute Coronary Syndromes.	Journal of Cardiovascular Translational Research	2021
34423649	Long-Term Ticagrelor in Patients With Prior Coronary Stenting in the PEGASUS-TIMI 54 Trial.	J Am Heart Assoc	2021
30588886	Long-Term Outcome of Acute Coronary Syndromes in Patients on Chronic Oral Anticoagulants: Data from the EPICOR Study.	Current Vascular Pharmacology	2020
31638646	Primary PCI and the indistinct 120 min time limit.	European Heart Journal	2020
32159359	Assessment of quality indicators for acute myocardial infarction management in 28 countries and use of composite quality indicators for benchmarking.	European Heart Journal: Acute Cardiovascular Care	2020
32215657	CardioScape-II: the need to map cardiovascular funding patterns in Europe.	Cardiovasc Res	2020
32484542	Implementing the new European Regulations on medical devices-clinical responsibilities for evidence-based practice: a report from the Regulatory Affairs Committee of the European Society of Cardiology.	European Heart Journal	2020
32621557	Association between glycated haemoglobin levels and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease: a secondary analysis of the TECOS randomized clinical trial.	Eur J Heart Fail	2020
33166997	Non-vitamin K oral anticoagulants in adults with congenital heart disease: quod non?	European Heart Journal	2020
32553932	The Second Strategic Reperfusion Early After Myocardial Infarction (STREAM-2) study optimizing pharmacoinvasive reperfusion strategy in older ST-elevation myocardial infarction patients.	American Heart Journal	2020
27357206	Report of the European Society of Cardiology Cardiovascular Round Table regulatory workshop update of the evaluation of new agents for the treatment of acute coronary syndrome: Executive summary.	European Heart Journal: Acute Cardiovascular Care	2019
31756302	Peripheral Blood RNA Levels of <i>QSOX1</i> and <i>PLBD1</i> Are New Independent Predictors of Left Ventricular Dysfunction After Acute Myocardial Infarction.	Circ Genom Precis Med	2019
28777005	Predicting two-year mortality from discharge after acute coronary syndrome: An internationally-based risk score.	European Heart Journal: Acute Cardiovascular Care	2019
30443916	Predictors of all-cause mortality and ischemic events within and beyond 1 year after an acute coronary syndrome: Results from the EPICOR registry.	Clinical Cardiology	2019
30586685	Prevention of Cardiogenic Shock After Acute Myocardial Infarction.	Circulation	2019
30496395	Endogenous fibrinolysis in STEMI: important before and after primary PCI.	European Heart Journal	2019
29611427	Impact of known or new-onset atrial fibrillation on 2-year cardiovascular event rate in patients with acute coronary syndromes: results from the prospective EPICOR Registry.	European Heart Journal: Acute Cardiovascular Care	2019
31218354	Efficacy and safety with ticagrelor in patients with prior myocardial infarction in the approved European label: insights from PEGASUS-TIMI 54.	Eur Heart J Cardiovasc Pharmacother	2019
30897348	Association of Chromosome 9p21 With Subsequent Coronary Heart Disease Events.	Circ Genom Precis Med	2019
31514947	In-Hospital Coronary Revascularization Rates and Post-Discharge Mortality Risk in Non-ST-Segment Elevation AcuteÂ Coronary Syndrome.	Journal of the American College of Cardiology	2019
29800130	Nitric oxide for inhalation in ST-elevation myocardial infarction (NOMI): a multicentre, double-blind, randomized controlled trial.	European Heart Journal	2018
28627230	Relationship between community hospital versus pre-hospital location of randomisation and clinical outcomes in ST-elevation myocardial infarction patients: insights from the Stream study.	European Heart Journal: Acute Cardiovascular Care	2018
28449050	CardioScape mapping the cardiovascular funding landscape in Europe.	Eur Heart J	2018
30115426	Previous and New Onset Atrial Fibrillation and Associated Outcomes in Acute Coronary Syndromes (from the Global Registry of Acute Coronary Events).	American Journal of Cardiology	2018
30017550	The need for transparency of clinical evidence for medical devices in Europe.	Lancet, The	2018
29923323	Sex differences in management and outcomes of patients with type 2 diabetes and cardiovascular disease: A report from TECOS.	Diabetes Obes Metab	2018
30055940	Effects of genetic variation in protease activated receptor 4 after an acute coronary syndrome: Analysis from the TRACER trial.	Blood Cells Mol Dis	2018
30338834	[Fourth universal definition of myocardial infarction (2018)].	Kardiol Pol	2018
29910048	Discharge timing and outcomes after uncomplicated non-ST-segment elevation acute myocardial infarction.	Am Heart J	2018
30380397	Is Culprit-Lesion-Only PCI in Cardiogenic Shock Still Better at 1 Year?	New England Journal of Medicine	2018
30571502	Reduction in Subtypes and Sizes of Myocardial Infarction With Ticagrelor in PEGASUS-TIMI 54.	J Am Heart Assoc	2018
30526198	Stroke Outcomes With Vorapaxar Versus Placebo in Patients With Acute Coronary Syndromes: Insights From the TRACER Trial.	J Am Heart Assoc	2018
29573215	Longitudinal medical resources and costs among type 2 diabetes patients participating in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS).	Diabetes Obes Metab	2018
29311155	Increased Risk of Severe Hypoglycemic Events Before and After Cardiovascular Outcomes in TECOS Suggests an At-Risk Type 2 Diabetes Frail Patient Phenotype.	Diabetes Care	2018
29663124	Regional variations in hospital management and post-discharge mortality in patients with non-ST-segment elevation acute coronary syndrome.	Clinical Research in Cardiology	2018
29747915	Prognostic and Practical Validation of Current Definitions of Myocardial Infarction Associated With PercutaneousÂ Coronary Intervention.	JACC Cardiovasc Interv	2018
29421012	Clinical features and outcomes of patients with type 2 myocardial infarction: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) trial.	Am Heart J	2018
29633231	Reperfusion treatment in acute myocardial infarction in elderly patients.	Kardiologia Polska	2018
28291730	Association Between Clinical Pathways Leading to Medical Management and Prognosis in Patients With NSTEACS.	Revista espanola de cardiologia (English ed.)	2017
28510709	Clopidogrel instead of prasugrel or ticagrelor after 1â¿¿month in stabilized ACS patients: back to square one for DAPT?	European Heart Journal	2017
28461411	Prevention of Cardiovascular Events in Patients With Diabetes: How Beneficial Is Dual Antiplatelet Therapy?	Circulation	2017
28986504	Causes of Death in a Contemporary Cohort of Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: Insights From the TECOS Trial.	Diabetes Care	2017